Metabolic Syndrome Explained: The Five Risk Factors That Often Travel Together

Metabolic risk rarely arrives as one dramatic event. More often, the pattern develops through small changes that accumulate over several years.

Waist circumference increases. Blood pressure moves from normal into the borderline range. Triglycerides rise while HDL cholesterol falls. Fasting glucose remains below the diabetic threshold but is no longer where it used to be.

Each finding deserves attention on its own. When several occur together, the pattern is called metabolic syndrome.

What Is Metabolic Syndrome?

Metabolic syndrome is a cluster of common cardiometabolic abnormalities associated with greater risk of type 2 diabetes and cardiovascular disease. It is diagnosed from routine clinical measurements rather than a specialized scan, genetic test or insulin assay.

Under the harmonized criteria developed by several major international organizations, a person meets the definition when at least three of five findings are present.

A person does not need all five findings. Abdominal obesity is not mandatory under the harmonized definition, and an insulin measurement is not part of the formal criteria.

Why Treatment Still Counts Toward the Diagnosis

Medication can improve a number without removing the underlying history. Someone whose blood pressure is controlled with medication still has treated hypertension. The same principle applies to glucose and triglycerides.

This prevents treatment from making a risk factor disappear on paper. The purpose of the criteria is to recognize the cardiometabolic pattern, including abnormalities already being managed.

Why the Cluster Matters

Metabolic syndrome is sometimes criticized because each of its components is already a recognized risk factor. A blood pressure of 150/95 requires treatment whether or not the person also meets the definition of metabolic syndrome. The same is true for diabetes or markedly elevated triglycerides.

The diagnosis remains useful because it draws attention to the way these findings travel together. A person who has a growing waistline, triglycerides of 170 mg/dL and fasting glucose of 103 mg/dL may not appear acutely ill. The combination suggests that glucose regulation, fat distribution and lipid metabolism are already changing.

Large studies and meta-analyses have associated metabolic syndrome with approximately twice the risk of cardiovascular events compared with not having the syndrome. The risk of developing type 2 diabetes is also substantially higher, although the exact estimate varies according to the population, definition and length of follow-up.

The diagnosis does not calculate an individual’s precise probability of having a heart attack or developing diabetes. It identifies a higher-risk pattern that deserves attention.

The Role of Insulin Resistance

Insulin resistance is common in metabolic syndrome, but it is not directly measured by the five diagnostic criteria.

As muscle, liver and fat tissue become less responsive to insulin, the pancreas often produces more insulin to maintain glucose control. Fasting glucose can remain below 100 mg/dL during this compensatory stage. This means someone can have insulin resistance without meeting the glucose criterion.

Conversely, metabolic syndrome can be diagnosed from three other criteria without a fasting-insulin measurement. The syndrome is defined by observable clinical findings, not by proving that one mechanism caused them all.

At HormoneSynergy®, fasting insulin and HOMA-IR may provide useful information beyond the formal criteria, particularly when glucose remains normal but visceral fat, triglycerides or other metabolic markers are moving in an unfavorable direction.

Read Why Insulin Resistance Causes Weight Gain for a more complete discussion.

Visceral Fat and Waist Circumference

Waist circumference serves as an accessible estimate of central adiposity. It is more informative about abdominal fat distribution than BMI alone, although it cannot distinguish the fat beneath the skin from visceral fat surrounding the organs.

Visceral adipose tissue is metabolically active. Excess visceral fat is associated with insulin resistance, abnormal triglyceride metabolism, fatty liver disease and inflammatory signaling. It can also be elevated in someone whose BMI does not fall within the obesity range.

Waist thresholds are not identical for every population. People of Asian ancestry, for example, may develop cardiometabolic risk at lower waist circumferences and BMI values. Sex, ethnicity, height and body composition should be considered rather than treating one number as universally appropriate.

Hologic® DEXA body composition analysis can add information that waist circumference cannot provide by estimating visceral adipose tissue and measuring total fat, regional fat, lean mass and bone density.

Read Why Visceral Fat Is Dangerous for more detail.

Triglycerides and HDL Cholesterol

The triglyceride and HDL criteria capture a common lipid pattern associated with insulin resistance. The liver may produce more triglyceride-rich VLDL particles, while HDL cholesterol falls as lipoproteins are remodeled in circulation.

These numbers do not provide a complete assessment of atherosclerotic risk. LDL cholesterol can appear unremarkable while ApoB, which reflects the number of atherogenic lipoprotein particles, is elevated. Lipoprotein(a), smoking, kidney disease, inflammatory conditions and family history may add risk that the metabolic-syndrome criteria do not capture.

Metabolic syndrome therefore does not replace a complete lipid and cardiovascular evaluation.

Blood Pressure

The blood-pressure threshold used for metabolic syndrome is 130/85 mm Hg, but one elevated office reading is not enough to establish a person’s usual blood pressure.

Technique matters. The patient should be seated and rested, the arm supported and the cuff appropriately sized. Home readings or ambulatory monitoring can help distinguish sustained hypertension from an isolated office elevation.

Insulin resistance, kidney sodium handling, sympathetic nervous-system activity, sleep apnea and excess visceral fat may all contribute to higher blood pressure. Regardless of the mechanism, persistent hypertension requires its own evaluation and treatment.

Fasting Glucose

A fasting glucose of 100 mg/dL or higher meets the metabolic-syndrome glucose criterion. It does not automatically establish diabetes.

Diabetes and prediabetes are diagnosed using recognized glucose or hemoglobin A1c thresholds, sometimes confirmed with repeat testing. Hemoglobin A1c is clinically useful even though it is not one of the original five metabolic-syndrome criteria.

Fasting glucose can also miss abnormal post-meal glucose or compensatory hyperinsulinemia. Depending on the situation, fasting insulin, an oral glucose-tolerance test or continuous glucose monitoring may provide additional context. A continuous glucose monitor measures glucose, not insulin, and does not diagnose insulin resistance by itself.

Metabolic Syndrome Is Often Silent

Most people do not feel their triglycerides rising or their blood pressure gradually increasing. Insulin resistance may also be present without obvious symptoms.

An enlarging waistline may be the only visible change. Even that clue can be missed when a person’s weight remains stable while muscle decreases and abdominal fat increases.

Waiting for excessive thirst, frequent urination, chest pain or another obvious symptom means waiting for a later stage of disease. Metabolic assessment is most useful before those problems develop.

Why Risk Often Rises During Midlife

Metabolic syndrome can occur at any age. It becomes more common during midlife as several influences begin to accumulate.

• Loss of muscle reduces an important site for glucose disposal.
• Daily movement and structured exercise may decline.
• Visceral and liver fat may increase.
• Sleep may become shorter or more fragmented.
• Obstructive sleep apnea becomes more common.
• Menopause can shift fat distribution toward the abdomen.
• Testosterone deficiency in men may accompany lower muscle mass and greater visceral fat.
• Medications, alcohol, chronic stress and highly processed food can add to the pattern.

There is no metabolic switch that activates on a person’s fortieth birthday. The process reflects changes in physiology, environment and behavior rather than age alone.

Metabolic Syndrome and Fatty Liver Disease

Fat accumulation within the liver commonly accompanies metabolic syndrome. The current term is metabolic dysfunction-associated steatotic liver disease, or MASLD.

Liver fat can increase glucose production, worsen insulin resistance and alter triglyceride metabolism. Liver enzymes may be elevated, but normal AST and ALT results do not completely exclude MASLD.

When risk is present, evaluation may include liver markers, imaging and noninvasive fibrosis assessment. A “liver detox” supplement is not an adequate response to possible fatty liver disease.

Metabolic Syndrome and CKM Syndrome Are Not Identical

Metabolic syndrome remains a commonly used five-criterion diagnosis. Cardiovascular-kidney-metabolic syndrome, or CKM syndrome, is a newer and broader framework developed by the American Heart Association and incorporated into a major 2026 clinical guideline.

CKM syndrome considers the connections among excess or dysfunctional adiposity, diabetes, chronic kidney disease and cardiovascular disease across a staged continuum. It incorporates kidney health and estimated cardiovascular risk more directly than the traditional metabolic-syndrome definition.

The two concepts overlap, but they are not interchangeable. Metabolic syndrome identifies a familiar cluster of five risk factors. CKM staging provides a wider framework for assessing how metabolic disease, kidney disease and cardiovascular risk interact.

What Metabolic Syndrome Does Not Measure

The five criteria are useful, but they do not include every important health risk. They do not directly measure:

• ApoB or atherogenic particle number
• Lipoprotein(a)
• Coronary or carotid plaque
• Kidney function or urine albumin
• Liver fat or fibrosis
• Visceral fat measured by imaging
• Muscle mass or strength
• Cardiorespiratory fitness
• Sleep apnea
• Smoking exposure
• Family history or genetic risk

A person who does not meet three criteria is not automatically low risk. Severe hypertension, high ApoB, diabetes, chronic kidney disease or substantial coronary plaque still requires attention even without the metabolic-syndrome label.

How Metabolic Syndrome Is Treated

There is no medication prescribed specifically to make the diagnosis disappear. Treatment addresses the individual abnormalities and the physiology connecting them.

Reduce Excess Visceral Fat

Loss of excess abdominal and liver fat can improve glucose regulation, triglycerides and blood pressure. The plan should be sustainable and should protect muscle and bone rather than pursuing scale weight alone.

Preserve and Build Muscle

Resistance training improves strength, preserves lean mass during weight loss and increases the body’s capacity to use glucose. Adequate protein supports that work.

Include Aerobic Activity and Daily Movement

Brisk walking, cycling, swimming and other aerobic exercise improve cardiorespiratory fitness and insulin sensitivity. Walking after meals can also reduce post-meal glucose exposure.

Improve Food Quality

A plant- and protein-forward Mediterranean eating pattern works well for many people. Vegetables, legumes, whole fruit, nuts, seeds, fish, minimally processed protein sources and adequate fiber can improve satiety and cardiometabolic health.

Reducing sugar-sweetened beverages, refined snack foods and other highly processed, calorie-dense foods is usually more useful than treating every carbohydrate as metabolically equivalent.

Address Sleep and Sleep Apnea

Insufficient sleep can worsen appetite regulation, blood pressure and insulin sensitivity. Loud snoring, witnessed breathing pauses, morning headaches or daytime sleepiness warrant evaluation for obstructive sleep apnea.

Treat Each Abnormal Risk Factor

Blood pressure, elevated ApoB or LDL cholesterol, high triglycerides, prediabetes and diabetes should be treated according to the individual’s overall risk. Lifestyle changes and medication are complementary rather than competing approaches.

Depending on the clinical situation, treatment may include antihypertensive medication, statin therapy, metformin, GLP-1–based medication or other evidence-based therapies. The choice depends on the person’s diagnoses, cardiovascular and kidney risk, tolerance and goals.

A HormoneSynergy® Approach to Metabolic Risk

At HormoneSynergy®, the five metabolic-syndrome criteria are a starting point rather than the entire assessment.

Dr. Kathryn Retzler may also evaluate fasting insulin, HOMA-IR, hemoglobin A1c, ApoB, lipoprotein(a), uric acid, liver markers, kidney function and inflammatory markers according to the patient’s history and risk. Hologic® DEXA measures visceral fat, total and regional fat, lean mass and bone density. SECA body-composition testing can help follow changes between DEXA scans.

Cardiovascular evaluation may extend beyond blood testing when the history or findings warrant direct assessment of vascular health or plaque. The purpose is to determine what is happening before the diagnosis becomes diabetes, fatty liver disease or clinically apparent cardiovascular disease.

Explore the HormoneSynergy® Longevity Medicine Resource Library for additional education on metabolic health, preventive cardiology, hormones, body composition and healthy aging.

The Bottom Line

Metabolic syndrome is diagnosed when at least three of five findings occur together: increased waist circumference, high triglycerides, low HDL cholesterol, elevated blood pressure and elevated fasting glucose.

The diagnosis is useful because it identifies a pattern. It does not replace attention to the individual numbers, nor does its absence prove that someone is metabolically or cardiovascularly healthy.

Early intervention can change the trajectory. Reducing excess visceral fat, preserving muscle, improving fitness, addressing sleep and food quality, and treating blood pressure, lipids and glucose when necessary can improve the individual components and reduce the risk they represent.

Selected Evidence and Guidelines

• Harmonizing the metabolic syndrome: joint interim statement
• Metabolic syndrome and cardiovascular risk: systematic review and meta-analysis
• Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes
• 2026 guideline for cardiovascular-kidney-metabolic syndrome
• American Diabetes Association Standards of Care in Diabetes—2026

Frequently Asked Questions

What is metabolic syndrome?

Metabolic syndrome is a clinical diagnosis based on five common cardiometabolic risk factors: increased waist circumference, high triglycerides, low HDL cholesterol, elevated blood pressure and elevated fasting glucose.

How many criteria are needed for metabolic syndrome?

Under the widely used harmonized definition, at least three of the five criteria must be present. A person does not need to meet all five.

Does abdominal obesity have to be present?

No. Increased waist circumference is one of the five criteria, but it is not mandatory under the harmonized definition. Any combination of three qualifying findings can establish the diagnosis.

Does insulin resistance have to be measured?

No. Insulin resistance is common in metabolic syndrome, but fasting insulin and HOMA-IR are not part of the formal five diagnostic criteria.

Does taking blood-pressure or glucose medication affect the criteria?

Yes. Treatment for previously diagnosed high blood pressure, elevated glucose or high triglycerides generally counts toward the corresponding criterion even when the current result is controlled.

Can someone be at high cardiovascular risk without metabolic syndrome?

Yes. ApoB, lipoprotein(a), smoking, chronic kidney disease, diabetes, inflammatory disease, family history and existing arterial plaque can confer substantial risk even when fewer than three metabolic-syndrome criteria are present.

Can metabolic syndrome be reversed?

Many people can improve enough that they no longer meet three criteria. Reducing visceral fat, increasing physical activity, preserving muscle, improving nutrition and sleep, and treating individual risk factors can all contribute. Ongoing follow-up remains important because the underlying tendency may return.

Is metabolic syndrome the same as CKM syndrome?

No. Metabolic syndrome is based on five traditional risk factors. Cardiovascular-kidney-metabolic syndrome is a broader staged framework that considers excess or dysfunctional adiposity, diabetes, kidney disease and cardiovascular risk together.